716 related articles for article (PubMed ID: 2865873)
1. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.
Radack K; Deck C
Arch Intern Med; 1991 Sep; 151(9):1769-76. PubMed ID: 1679624
[TBL] [Abstract][Full Text] [Related]
3. Lower limb haemodynamics during antihypertensive treatment with metoprolol and propranolol.
Lepäntalo MJ; Tötterman KJ
Int Angiol; 1985; 4(2):225-8. PubMed ID: 3831144
[TBL] [Abstract][Full Text] [Related]
4. Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication.
Lepäntalo M
Clin Pharmacol Ther; 1985 Jan; 37(1):7-12. PubMed ID: 3880687
[TBL] [Abstract][Full Text] [Related]
5. Beta blockers for peripheral arterial disease.
Paravastu SC; Mendonca DA; Da Silva A
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD005508. PubMed ID: 24027118
[TBL] [Abstract][Full Text] [Related]
6. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
[TBL] [Abstract][Full Text] [Related]
7. Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication.
Lepäntalo M
Br J Clin Pharmacol; 1984 Jul; 18(1):90-3. PubMed ID: 6378235
[TBL] [Abstract][Full Text] [Related]
8. Beta blockers for peripheral arterial disease.
Paravastu SC; Mendonca DA; da Silva A
Eur J Vasc Endovasc Surg; 2009 Jul; 38(1):66-70. PubMed ID: 19359199
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral vascular effects of metoprolol, pindolol and propranolol in hypertensive patients].
Joyal F; Bourque M; Kuchel O; Larochelle P
J Pharmacol; 1983; 14 Suppl 2():107-15. PubMed ID: 6138462
[TBL] [Abstract][Full Text] [Related]
10. Peripheral arterial insufficiency, effect of physical training on walking tolerance, calf blood flow, and blood flow resistance.
Dahllöf AG; Holm J; Scherstén T; Sivertsson R
Scand J Rehabil Med; 1976; 8(1):. PubMed ID: 935836
[TBL] [Abstract][Full Text] [Related]
11. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil JJ; Louis WJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
[TBL] [Abstract][Full Text] [Related]
12. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
Roberts DH; Tsao Y; McLoughlin GA; Breckenridge A
Lancet; 1987 Sep; 2(8560):650-3. PubMed ID: 2887941
[TBL] [Abstract][Full Text] [Related]
13. Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication.
Diehm C; Pittrow D; Lawall H
J Hypertens; 2011 Jul; 29(7):1448-56. PubMed ID: 21602713
[TBL] [Abstract][Full Text] [Related]
14. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
15. Behavior of calf blood flow in normal subjects and in patients with intermittent claudication during a 24-h time span.
Bartoli V; Dorigo B; Tedeschi E; Biti G; Voegelin MR
Chronobiologia; 1975; 2(1):13-9. PubMed ID: 1192904
[TBL] [Abstract][Full Text] [Related]
16. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
[TBL] [Abstract][Full Text] [Related]
17. Lower limb movement variability in patients with peripheral arterial disease.
Crowther RG; Spinks WL; Leicht AS; Quigley F; Golledge J
Clin Biomech (Bristol, Avon); 2008 Oct; 23(8):1080-5. PubMed ID: 18495306
[TBL] [Abstract][Full Text] [Related]
18. Observations on changes in intermittent claudication after the administration of creatine phosphate.
Favilli S; Iacopetti L; Fradella GA; Righi D; Nuzzaci G
Pharmatherapeutica; 1982; 3(4):221-6. PubMed ID: 7146037
[TBL] [Abstract][Full Text] [Related]
19. Walking capacity of patients with intermittent claudication during chronic antihypertensive treatment with metoprolol and methyldopa.
Lepäntalo M; von Knorring J
Clin Physiol; 1984 Aug; 4(4):275-82. PubMed ID: 6380905
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic administration of selective betablockers on peripheral circulation of the lower limbs in patients with essential hypertension.
Novo S; Pinto A; Galati D; Giannola A; Forte G; Strano A
Int Angiol; 1985; 4(2):229-34. PubMed ID: 2870124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
